Evidence for an enhanced procoagulant state in remitted major depression

References

• Abbate R, Cioni G, Ricci I, Miranda M, Gori AM. 2012. Thrombosis and acute coronary syndrome. Thromb Res. 129(3):235–240.
   PubMed Web of Science ®Google Scholar
• Amadio P, Colombo GI, Tarantino E, Gianellini S, Ieraci A, Brioschi M, Banfi C, Werba JP, Parolari A, Lee FS, et al. 2017. BDNFVal66met polymorphism: a potential bridge between depression and thrombosis. Eur Heart J. 38(18):1426–1435.
   PubMed Web of Science ®Google Scholar
• Austin AW, Wissmann T, von Kanel R. 2013. Stress and hemostasis: an update. Semin Thromb Hemost. 39(08):902–912.
   PubMed Web of Science ®Google Scholar
• Baune BT, Smith E, Reppermund S, Air T, Samaras K, Lux O, Brodaty H, Sachdev P, Trollor JN. 2012. Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: the prospective Sydney Memory and Aging Study. Psychoneuroendocrinology. 37(9):1521–1530.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, et al. 2017. Heart Disease and Stroke Statistics-2017 update: a report from the American Heart Association. Circulation. 135(10):e146–e603.
   PubMed Web of Science ®Google Scholar
• Borissoff JI, Heeneman S, Kilinç E, KašŠÁk P, Van Oerle R, Winckers K, Govers-Riemslag JWP, Hamulyák K, Hackeng TM, Daemen MJAP, et al. 2010. Early atherosclerosis exhibits an enhanced procoagulant state. Circulation. 122(8):821–830.
   PubMed Web of Science ®Google Scholar
• Borissoff JI, Spronk HM, ten Cate H. 2011. The hemostatic system as a modulator of atherosclerosis. N Engl J Med. 364(18):1746–1760.
   PubMed Web of Science ®Google Scholar
• Bot M, Chan MK, Jansen R, Lamers F, Vogelzangs N, Steiner J, Leweke FM, Rothermundt M, Cooper J, Bahn S, et al. 2015. Serum proteomic profiling of major depressive disorder. Transl Psychiatry. 5(7):e599.
   PubMed Web of Science ®Google Scholar
• Brenner B, Gris JC. 2013. Coagulation and brain. Semin Thromb Hemost. 39:847–848.
   PubMed Web of Science ®Google Scholar
• Charlson FJ, Moran AE, Freedman G, Norman RE, Stapelberg NJ, Baxter AJ, Vos T, Whiteford HA. 2013. The contribution of major depression to the global burden of ischemic heart disease: a comparative risk assessment. BMC Med. 11(1):250.
   PubMed Web of Science ®Google Scholar
• Cohen J. 1988. Statistical power analysis for the behavioral sciences. Hillsdale (NJ): Erlbaum.
   Google Scholar
• Delle Chiaie R, Capra E, Salviati M, Trabucchi G, Pancheri C, Corrado A, Biondi M. 2013. Persistence of subsyndromal residual symptoms after remission of major depression in patients without cardiovascular disease may condition maintenance of elevated platelet factor 4 and β-thromboglobulin plasma levels. J Affect Disord. 150(2):664–667.
   PubMed Web of Science ®Google Scholar
• Dentino AN, Pieper CF, Rao MK, Currie MS, Harris T, Blazer DG, Cohen HJ. 1999. Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc. 47(1):6–11.
   PubMed Web of Science ®Google Scholar
• Diamond SL. 2013. Systems biology of coagulation. J Thromb Haemost. 11(1):224–232.
   PubMed Web of Science ®Google Scholar
• Dietrich-Muszalska A, Wachowicz B. 2017. Platelet haemostatic function in psychiatric disorders: effects of antidepressants and antipsychotic drugs. World J Biol Psychiatry. 18(8):564–574.
   PubMed Web of Science ®Google Scholar
• Eskandari F, Mistry S, Martinez PE, Torvik S, Kotila C, Sebring N, Drinkard BE, Levy C, Reynolds JC, Csako G, et al. 2005. Younger, premenopausal women with major depressive disorder have more abdominal fat and increased serum levels of prothrombotic factors: implications for greater cardiovascular risk. Metabolism. 54(7):918–924.
   PubMed Web of Science ®Google Scholar
• Esmon CT. 2005. The interactions between inflammation and coagulation. Br J Haematol. 131(4):417–430.
   PubMed Web of Science ®Google Scholar
• Faul F, Erdfelder E, Lang AG, Buchner A. 2007. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 39(2):175–191.
   PubMed Web of Science ®Google Scholar
• Fibrinogen Studies Collaboration. 2015. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA. 294:1799–1809.
   Google Scholar
• Gan Y, Gong Y, Tong X, Sun H, Cong Y, Dong X, Wang Y, Xu X, Yin X, Deng J, et al. 2014. Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies. BMC Psychiatry. 14(1):371.
   PubMed Web of Science ®Google Scholar
• Geiser F, Gessler K, Conrad R, Imbierowicz K, Albus C, Harbrecht U. 2012. Can activation of coagulation and impairment of fibrinolysis in patients with anxiety and depression be reversed after improvement of psychiatric symptoms? Results of a pilot study. J Nerv Ment Dis. 200(8):721–723.
   PubMed Web of Science ®Google Scholar
• Geiser F, Meier C, Wegener I, Imbierowicz K, Conrad R, Liedtke R, Oldenburg J, Harbrecht U. 2008. Association between anxiety and factors of coagulation and fibrinolysis. Psychother Psychosom. 77(6):377–383.
   PubMed Web of Science ®Google Scholar
• Hautzinger M, Keller F, Kühner C. 2006. BDI-II-Beck depressions-inventar revision. Frankfurt (Germany): Pearson.
   Google Scholar
• Höhne N, Poidinger M, Merz F, Pfister H, Brückl T, Zimmermann P, Uhr M, Holsboer F, Ising M. 2014. Increased HPA axis response to psychosocial stress in remitted depression: the influence of coping style. Biol Psychol. 103:267–275.
   PubMed Web of Science ®Google Scholar
• Höhne N, Poidinger M, Merz F, Pfister H, Brückl T, Zimmermann P, Uhr M, Holsboer F, Ising M. 2015. FKBP5 genotype-dependent DNA methylation and mRNA regulation after psychosocial stress in remitted depression and healthy controls. Int J Neuropsychopharmacol. 18:1–9.
   Web of Science ®Google Scholar
• Howren MB, Lamkin DM, Suls J. 2009. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 71(2):171–186.
   PubMed Web of Science ®Google Scholar
• Janszky I, Ahlbom A, Hallqvist J, Ahnve S. 2007. Hospitalization for depression is associated with an increased risk for myocardial infarction not explained by lifestyle, lipids, coagulation, and inflammation: the SHEEP Study. Biol Psychiatry. 62(1):25–32.
   PubMed Web of Science ®Google Scholar
• Jung RG, Motazedian P, Ramirez FD, Simard T, Di Santo P, Visintini S, Faraz MA, Labinaz A, Jung Y, Hibbert B. 2018. Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis. Thromb J. 16:12.
   PubMed Web of Science ®Google Scholar
• Kaplan KL, Bini A, Fenoglio J, Jr, Kudryk B. 1990. Fibrin and the vessel wall. Adv Exp Med Biol. 281:313–318.
   PubMedGoogle Scholar
• Kling MA, Alesci S, Csako G, Costello R, Luckenbaugh DA, Bonne O, Duncko R, Drevets WC, Manji HK, Charney DS, et al. 2007. Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A. Biol Psychiatry. 62(4):309–313.
   PubMed Web of Science ®Google Scholar
• Lahlou-Laforet K, Alhenc-Gelas M, Pornin M, Bydlowski S, Seigneur E, Benetos A, Kierzin JM, Scarabin PY, Ducimetiere P, Aiach M, et al. 2006. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease. Am J Cardiol. 97(9):1287–1291.
   PubMed Web of Science ®Google Scholar
• Laux L, Glanzmann P, Schaffner P, Spielberger CD. 1981. Das State-Trait-Angstinventar. Theoretische Grundlagen und Handanweisung. Weinheim (Germany): Beltz Test GmbH.
   Google Scholar
• Lieb R, Isensee B, von Sydow K, Wittchen HU. 2000. The Early Developmental Stages of Psychopathology Study (EDSP): a methodological update. Eur Addict Res. 6(4):170–182.
   PubMed Web of Science ®Google Scholar
• Lim GY, Tam WW, Lu Y, Ho CS, Zhang MW, Ho RC. 2018. Prevalence of depression in the community from 30 countries between 1994 and 2014. Sci Rep. 8(1):2861.
   PubMed Web of Science ®Google Scholar
• Loeffen R, Spronk HM, ten Cate H. 2012. The impact of blood coagulability on atherosclerosis and cardiovascular disease. J Thromb Haemost. 10(7):1207–1216.
   PubMed Web of Science ®Google Scholar
• Lopez-Vilchez I, Diaz-Ricart M, Navarro V, Torramade S, Zamorano-Leon J, Lopez-Farre A, Galan AM, Gasto C, Escolar G. 2016. Endothelial damage in major depression patients is modulated by SSRI treatment, as demonstrated by circulating biomarkers and an in vitro cell model. Transl Psychiatry. 6(9):e886.
   PubMed Web of Science ®Google Scholar
• Lopez-Vilchez I, Serra-Millas M, Navarro V, Rosa Hernandez M, Villalta J, Diaz-Ricart M, Gasto C, Escolar G, Galan AM. 2014. Prothrombotic platelet phenotype in major depression: downregulation by antidepressant treatment. J Affect Disord. 159:39–45.
   PubMed Web of Science ®Google Scholar
• Maes M, Delange J, Ranjan R, Meltzer HY, Desnyder R, Cooremans W, Scharpé S. 1997. Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res. 66(1):1–11.
   PubMed Web of Science ®Google Scholar
• Morel-Kopp MC, McLean L, Chen Q, Tofler GH, Tennant C, Maddison V, Ward CM. 2009. The association of depression with platelet activation: evidence for a treatment effect. J Thromb Haemost. 7(4):573–581.
   PubMed Web of Science ®Google Scholar
• Morris MC, Rao U. 2014. Cortisol response to psychosocial stress during a depressive episode and remission. Stress. 17(1):51–58.
   PubMed Web of Science ®Google Scholar
• Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, et al. 2003. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 107:499–511.
   PubMed Web of Science ®Google Scholar
• Ruland T, Chan MK, Stocki P, Grosse L, Rothermundt M, Cooper JD, Arolt V, Bahn S. 2016. Molecular serum signature of treatment resistant depression. Psychopharmacology (Berl). 233(15–16):3051–3059.
   PubMed Web of Science ®Google Scholar
• Sabater-Lleal M, Huffman JE, de Vries PS, Marten J, Mastrangelo MA, Song C, Pankratz N, Ward-Caviness CK, Yanek LR, Trompet S, et al. 2019. Genome-wide association transethnic meta-analyses identifies novel associations regulating coagulation factor VIII and von Willebrand factor plasma levels. Circulation. 139(5):620–635.
   PubMed Web of Science ®Google Scholar
• Salomon K, Bylsma LM, White KE, Panaite V, Rottenberg J. 2013. Is blunted cardiovascular reactivity in depression mood-state dependent? A comparison of major depressive disorder remitted depression and healthy controls. Int J Psychophysiol. 90(1):50–57.
   PubMed Web of Science ®Google Scholar
• Song C, Burgess S, Eicher JD, O’Donnell CJ, Johnson AD. 2017. Causal effect of plasminogen activator inhibitor type 1 on coronary heart disease. J Am Heart Assoc. 6:6.
   Web of Science ®Google Scholar
• Stapelberg NJ, Neumann DL, Shum DH, McConnell H, Hamilton-Craig I. 2011. A topographical map of the causal network of mechanisms underlying the relationship between major depressive disorder and coronary heart disease. Aust N Z J Psychiatry. 45(5):351–369.
   PubMed Web of Science ®Google Scholar
• Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. 2016. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 37(42):3232–3245.
   PubMed Web of Science ®Google Scholar
• Vaccarino V, Badimon L, Bremner JD, Cenko E, Cubedo J, Dorobantu M, Duncker DJ, Koller A, Manfrini O, Milicic D, et al. 2019. Depression and coronary heart disease: 2018 ESC position paper of the working group of coronary pathophysiology and microcirculation developed under the auspices of the ESC Committee for Practice Guidelines. Eur Heart J. DOI:10.1093/eurheartj/ehy913
   PubMed Web of Science ®Google Scholar
• Vaughan DE. 2005. PAI-1 and atherothrombosis. J Thromb Haemost. 3(8):1879–1883.
   PubMed Web of Science ®Google Scholar
• Vignali DA. 2000. Multiplexed particle-based flow cytometric assays. J Immunol Methods. 243(1–2):243–255.
   PubMed Web of Science ®Google Scholar
• von Känel R, Mausbach BT, Dimsdale JE, Mills PJ, Patterson TL, Ancoli-Israel S, Ziegler MG, Roepke SK, Allison M, Grant I. 2010. Problem behavior of dementia patients predicts low-grade hypercoagulability in spousal caregivers. J Gerontol A Biol Sci Med Sci. 65:1004–1011.
   PubMed Web of Science ®Google Scholar
• Willeit P, Thompson A, Aspelund T, Rumley A, Eiriksdottir G, Lowe G, Gudnason V, Di Angelantonio E. 2013. Hemostatic factors and risk of coronary heart disease in general populations: new prospective study and updated meta-analyses. PLoS One. 8(2):e55175.
   PubMed Web of Science ®Google Scholar
• Wittchen HU, Pfister H. 1997. DIA-X-Interviews: Manual für Screening-Verfahren und Interview. Interviewheft Längsschnittuntersuchung (DIA-X lifetime); Ergänzungsheft (DIA-X); Interviewheft Querschnittsuntersuchung (DIA-X 12 Monate); Ergänzungsheft (DIA-X 12 Monate). Frankfurt (Germany): Swets & Zeitlinger.
   Google Scholar
• Wium-Andersen MK, Orsted DD, Nordestgaard BG. 2013. Association between elevated plasma fibrinogen and psychological distress, and depression in 73,367 individuals from the general population. Mol Psychiatry. 8:854–855.
   Web of Science ®Google Scholar
• Wu MD, Atkinson TM, Lindner JR. 2017. Platelets and von Willebrand factor in atherogenesis. Blood. 129(11):1415–1419.
   PubMed Web of Science ®Google Scholar